US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 44.300
  • -0.620-1.38%
Close Dec 4 16:00 ET
  • 44.300
  • 0.0000.00%
Post 16:06 ET
2.13BMarket Cap14.72P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
5.90%191.21M
25.17%182.39M
22.72%171.84M
29.14%644.4M
31.91%178.11M
50.30%180.56M
18.02%145.71M
16.33%140.02M
13.98%498.99M
11.69%135.02M
Operating revenue
24.34%188.82M
23.11%179.39M
12.57%157.63M
18.89%593.24M
15.28%155.65M
26.41%151.86M
18.02%145.71M
16.33%140.02M
13.98%498.99M
11.69%135.02M
Cost of revenue
23.73%89.27M
19.53%87.23M
23.50%81.74M
17.25%293.27M
28.36%81.97M
17.10%72.15M
21.40%72.97M
2.54%66.18M
5.08%250.13M
-1.23%63.86M
Gross profit
-5.96%101.94M
30.83%95.17M
22.02%90.1M
41.09%351.12M
35.09%96.14M
85.27%108.4M
14.81%72.74M
32.27%73.84M
24.59%248.86M
26.56%71.17M
Operating expense
25.66%44.89M
11.46%39.95M
4.17%42.09M
9.03%154.13M
26.47%42.16M
1.26%35.73M
-6.98%35.84M
18.11%40.41M
8.86%141.36M
4.23%33.34M
Selling and administrative expenses
24.95%23.82M
17.36%22.3M
21.63%25.05M
20.72%80.39M
35.04%21.74M
13.67%19.06M
20.74%19M
14.47%20.59M
-3.38%66.59M
9.55%16.1M
-Selling and marketing expense
40.39%9M
34.15%9.01M
31.82%9.37M
34.01%28.85M
57.51%8.62M
33.93%6.41M
16.71%6.72M
28.81%7.11M
23.13%21.53M
34.28%5.47M
-General and administrative expense
17.13%14.82M
8.18%13.29M
16.26%15.68M
14.38%51.54M
23.47%13.12M
5.59%12.65M
23.07%12.28M
8.12%13.48M
-12.39%45.06M
0.07%10.63M
Research and development costs
26.48%21.08M
4.80%17.65M
-13.99%17.04M
-1.38%73.74M
18.47%20.42M
-9.99%16.66M
-26.12%16.84M
22.14%19.82M
22.71%74.77M
-0.29%17.24M
Operating profit
-21.51%57.05M
49.66%55.22M
43.60%48.01M
83.25%196.99M
42.68%53.98M
212.89%72.68M
48.64%36.9M
54.68%33.43M
53.82%107.5M
56.00%37.83M
Net non-operating interest income expense
65.83%-4.27M
-104.98%-5.27M
-1,251.14%-6.06M
-4,033.14%-21.7M
-13,855.77%-7.15M
-5,219.15%-12.5M
-1,430.95%-2.57M
402.30%526K
-84.86%-525K
572.73%52K
Non-operating interest income
101.91%2.43M
223.98%3.34M
176.62%2.56M
313.25%5.46M
297.07%2.3M
263.14%1.2M
349.78%1.03M
410.50%924K
119.80%1.32M
269.43%580K
Non-operating interest expense
-51.12%6.7M
139.01%8.61M
2,063.57%8.61M
1,371.18%27.16M
1,690.91%9.46M
2,320.85%13.7M
807.30%3.6M
12.11%398K
108.59%1.85M
214.29%528K
Other net income (expense)
-247.27%-5.09M
119.66%298K
1,618.21%5.92M
-143.33%-3.93M
-262.38%-5.48M
971.28%3.46M
-0.80%-1.52M
-105.14%-390K
-37.62%9.07M
15.58%3.38M
Other non- operating income (expenses)
-247.27%-5.09M
119.66%298K
1,618.21%5.92M
-143.33%-3.93M
-262.38%-5.48M
971.28%3.46M
-0.80%-1.52M
-105.14%-390K
-37.62%9.07M
15.58%3.38M
Income before tax
-25.07%47.68M
53.14%50.24M
42.62%47.88M
47.67%171.36M
0.21%41.35M
181.63%63.64M
41.71%32.81M
15.62%33.57M
37.91%116.04M
51.90%41.26M
Income tax
-48.28%7.25M
92.61%12.29M
-38.89%4.13M
35.59%31.83M
-35.90%4.67M
113.83%14.03M
14.99%6.38M
65.61%6.75M
13.80%23.48M
1.33%7.29M
Earnings from equity interest net of tax
--0
--0
27.01%-573K
-68.31%-1.98M
-785.96%-505K
-139.26%-390K
-18.50%-301K
-11.66%-785K
-465.87%-1.18M
72.60%-57K
Net income
-17.86%40.43M
45.26%37.95M
65.86%43.18M
50.51%137.55M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
44.37%91.39M
71.62%33.91M
Net income continuous Operations
-17.86%40.43M
45.26%37.95M
65.86%43.18M
50.51%137.55M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
44.37%91.39M
71.62%33.91M
Minority interest income
0
0
Net income attributable to the parent company
-17.86%40.43M
45.26%37.95M
65.86%43.18M
50.51%137.55M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
47.12%91.39M
71.62%33.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.86%40.43M
45.26%37.95M
65.86%43.18M
50.51%137.55M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
47.12%91.39M
71.62%33.91M
Basic earnings per share
-17.82%0.83
42.59%0.77
66.67%0.9
51.60%2.85
7.14%0.75
215.63%1.01
54.29%0.54
8.00%0.54
44.62%1.88
70.73%0.7
Diluted earnings per share
-14.29%0.78
48.98%0.73
62.00%0.81
49.43%2.6
3.03%0.68
203.33%0.91
48.48%0.49
6.38%0.5
39.20%1.74
69.23%0.66
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 5.90%191.21M25.17%182.39M22.72%171.84M29.14%644.4M31.91%178.11M50.30%180.56M18.02%145.71M16.33%140.02M13.98%498.99M11.69%135.02M
Operating revenue 24.34%188.82M23.11%179.39M12.57%157.63M18.89%593.24M15.28%155.65M26.41%151.86M18.02%145.71M16.33%140.02M13.98%498.99M11.69%135.02M
Cost of revenue 23.73%89.27M19.53%87.23M23.50%81.74M17.25%293.27M28.36%81.97M17.10%72.15M21.40%72.97M2.54%66.18M5.08%250.13M-1.23%63.86M
Gross profit -5.96%101.94M30.83%95.17M22.02%90.1M41.09%351.12M35.09%96.14M85.27%108.4M14.81%72.74M32.27%73.84M24.59%248.86M26.56%71.17M
Operating expense 25.66%44.89M11.46%39.95M4.17%42.09M9.03%154.13M26.47%42.16M1.26%35.73M-6.98%35.84M18.11%40.41M8.86%141.36M4.23%33.34M
Selling and administrative expenses 24.95%23.82M17.36%22.3M21.63%25.05M20.72%80.39M35.04%21.74M13.67%19.06M20.74%19M14.47%20.59M-3.38%66.59M9.55%16.1M
-Selling and marketing expense 40.39%9M34.15%9.01M31.82%9.37M34.01%28.85M57.51%8.62M33.93%6.41M16.71%6.72M28.81%7.11M23.13%21.53M34.28%5.47M
-General and administrative expense 17.13%14.82M8.18%13.29M16.26%15.68M14.38%51.54M23.47%13.12M5.59%12.65M23.07%12.28M8.12%13.48M-12.39%45.06M0.07%10.63M
Research and development costs 26.48%21.08M4.80%17.65M-13.99%17.04M-1.38%73.74M18.47%20.42M-9.99%16.66M-26.12%16.84M22.14%19.82M22.71%74.77M-0.29%17.24M
Operating profit -21.51%57.05M49.66%55.22M43.60%48.01M83.25%196.99M42.68%53.98M212.89%72.68M48.64%36.9M54.68%33.43M53.82%107.5M56.00%37.83M
Net non-operating interest income expense 65.83%-4.27M-104.98%-5.27M-1,251.14%-6.06M-4,033.14%-21.7M-13,855.77%-7.15M-5,219.15%-12.5M-1,430.95%-2.57M402.30%526K-84.86%-525K572.73%52K
Non-operating interest income 101.91%2.43M223.98%3.34M176.62%2.56M313.25%5.46M297.07%2.3M263.14%1.2M349.78%1.03M410.50%924K119.80%1.32M269.43%580K
Non-operating interest expense -51.12%6.7M139.01%8.61M2,063.57%8.61M1,371.18%27.16M1,690.91%9.46M2,320.85%13.7M807.30%3.6M12.11%398K108.59%1.85M214.29%528K
Other net income (expense) -247.27%-5.09M119.66%298K1,618.21%5.92M-143.33%-3.93M-262.38%-5.48M971.28%3.46M-0.80%-1.52M-105.14%-390K-37.62%9.07M15.58%3.38M
Other non- operating income (expenses) -247.27%-5.09M119.66%298K1,618.21%5.92M-143.33%-3.93M-262.38%-5.48M971.28%3.46M-0.80%-1.52M-105.14%-390K-37.62%9.07M15.58%3.38M
Income before tax -25.07%47.68M53.14%50.24M42.62%47.88M47.67%171.36M0.21%41.35M181.63%63.64M41.71%32.81M15.62%33.57M37.91%116.04M51.90%41.26M
Income tax -48.28%7.25M92.61%12.29M-38.89%4.13M35.59%31.83M-35.90%4.67M113.83%14.03M14.99%6.38M65.61%6.75M13.80%23.48M1.33%7.29M
Earnings from equity interest net of tax --0--027.01%-573K-68.31%-1.98M-785.96%-505K-139.26%-390K-18.50%-301K-11.66%-785K-465.87%-1.18M72.60%-57K
Net income -17.86%40.43M45.26%37.95M65.86%43.18M50.51%137.55M6.65%36.17M210.08%49.22M50.61%26.12M7.34%26.03M44.37%91.39M71.62%33.91M
Net income continuous Operations -17.86%40.43M45.26%37.95M65.86%43.18M50.51%137.55M6.65%36.17M210.08%49.22M50.61%26.12M7.34%26.03M44.37%91.39M71.62%33.91M
Minority interest income 00
Net income attributable to the parent company -17.86%40.43M45.26%37.95M65.86%43.18M50.51%137.55M6.65%36.17M210.08%49.22M50.61%26.12M7.34%26.03M47.12%91.39M71.62%33.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.86%40.43M45.26%37.95M65.86%43.18M50.51%137.55M6.65%36.17M210.08%49.22M50.61%26.12M7.34%26.03M47.12%91.39M71.62%33.91M
Basic earnings per share -17.82%0.8342.59%0.7766.67%0.951.60%2.857.14%0.75215.63%1.0154.29%0.548.00%0.5444.62%1.8870.73%0.7
Diluted earnings per share -14.29%0.7848.98%0.7362.00%0.8149.43%2.63.03%0.68203.33%0.9148.48%0.496.38%0.539.20%1.7469.23%0.66
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cannabis & Hemp
Cannabis & Hemp
Intraday-0.08%